Parkinson Disease, Secondary (pathology) < Parkinson Disease, Secondary (physiopathology) < Parkinson Disease, Secondary (prevention & control)

Facettes :

List of bibliographic references indexed by Parkinson Disease, Secondary (physiopathology)

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]

Ident.	Authors (with country if any)	Title
000055 (2017)	Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil]	Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
000508 (2015)	Jackalina M. Van Kampen [Canada] ; David C. Baranowski [Canada] ; Harold A. Robertson [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay [Canada]	The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease
001123 (2012)	Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel Cyr	Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
001703 (2011)	Boris Rosin [Israël] ; Maya Slovik ; Rea Mitelman ; Michal Rivlin-Etzion ; Suzanne N. Haber ; Zvi Israel ; Eilon Vaadia ; Hagai Bergman	Closed-loop deep brain stimulation is superior in ameliorating parkinsonism.
001756 (2011)	Deepak Gupta [Canada] ; Abraham Kuruvilla [Inde]	Vascular parkinsonism: what makes it different?
001996 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie	Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001E00 (2009)	Mallika Somayajulu-Ni U [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Marianna Sikorska [Canada] ; Ts Sridhar [Canada, Inde] ; Anca Matei [Canada] ; Henryk Borowy-Borowski [Canada] ; Siyaram Pandey [Canada]	Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10
001E50 (2009)	Francesca Cicchetti [Canada] ; Janelle Drouin-Ouellet ; Robert E. Gross	Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
002491 (2007)	Elena I. Miklyaeva [Canada] ; Ian Q. Whishaw ; Bryan Kolb	A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.
002E39 (2003)	Clement Hamani [Canada] ; Andres M. Lozano [Canada]	Physiology and Pathophysiology of Parkinson's Disease
002F15 (2003)	Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Paul J. Bedard [Canada]	Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems
002F19 (2003)	Jackalina Van Kampen [Canada] ; Harold Robertson [Canada] ; Theo Hagg [Canada] ; Robert Drobitch [Canada]	Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease
003109 (2001)	C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O Poulter	Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
003361 (2000)	I. Mendez [Canada] ; K A Baker ; M. Hong	Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease.
003507 (2000)	Chong S. Lee [Canada] ; M. Angela Cenci [Suède] ; Michael Schulzer [Canada] ; Anders Bjo Rklund [Suède]	Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
003821 (1999)	G. D. Muir [Canada] ; I. Q. Whishaw [Canada]	Ground reaction forces in locomoting hemi-parkinsonian rats : a definitive test for impairments and compensations
003A69 (1997)	K D Davis [Canada] ; E. Taub ; S. Houle ; A E Lang ; J O Dostrovsky ; R R Tasker ; A M Lozano	Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms.
003A92 (1997)	Elena I. Miklyaeva [Canada] ; Nicole C. Woodward [Canada] ; Edouard G. Nikiforov [Canada] ; Greg J. Tompkins [Canada] ; Frank Klassen [Canada] ; Marat E. Ioffe [Canada] ; Ian Q. Whishaw [Canada]	The ground reaction forces of postural adjustments during skilled reaching in unilateral dopamine-depleted hemiparkinson rats
003B15 (1997)	Ian Q. Whishaw [Canada] ; Brenda L. K. Coles [Canada] ; Sergio M. Pellis [Canada] ; Elena I. Miklyaeva [Canada]	Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease
003C40 (1997)	R. Grondin [Canada] ; P. J. Bedard [Canada] ; D. R. Britton [États-Unis] ; K. Shiosaki [États-Unis]	Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929 : An acute study in parkinsonian levodopa-primed monkeys
003C75 (1997)	D. D. Newman [Canada] ; N. Rajakumar ; B. A. Flumerfelt ; A. J. Stoessl [Canada]	A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease, Secondary (physiopathology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (physiopathology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (physiopathology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022